Compound ID | 1380
Polymyxin B
Synonym(s): Polymixin B
Class: Polymyxin
| Spectrum of activity: | Gram-negative |
| Details of activity: | Used in the treatment of Gram-Negative infections. Relatively neurotoxic and nephrotoxic. Last resort antibiotic |
| Institute where first reported: | Adrastea Pharma |
| Year first mentioned: | 1964 |
| Highest developmental phase: | Approved by FDA in 1994 |
| Development status: | Approved |
| Reason Dropped: | Several formulations have been discontinued |
| External links: | |
| PubMed link: | https://pubmed.ncbi.nlm.nih.gov/17878146/ |
| Citation: | https://www.drugbank.ca/drugs/DB00781 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.